Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL3044047 | 0.83 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL3036369 | 0.81 | CNR2 (0.69) | CNR2CNR1 | |
| SCHEMBL3036374 | 0.79 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL3045971 | 0.79 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL3038903 | 0.78 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL3047245 | 0.78 | CNR2 (0.90) | CNR2CNR1 | |
| SCHEMBL3044580 | 0.78 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL3042547 | 0.78 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL3210501 | 0.77 | CNR2 (1.00) | CNR2CNR1 | |
| SCHEMBL3049347 | 0.76 | CNR2 (0.70) | CNR2CNR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2139852-A1 | SULFONAMIDE DERIVATIVES WITH THERAPEUTIC INDICATIONS | Pharmos Corporation (US) | 2010-01-06 | — | — | EP | claimed |
| WO-2008075353-A1 | SULFONAMIDE DERIVATIVES WITH THERAPEUTIC INDICATIONS | PHARMOS CORPORATION (US) | 2008-06-26 | — | — | WO | claimed |
| EP-2139852-A1 | SULFONAMIDE DERIVATIVES WITH THERAPEUTIC INDICATIONS | Pharmos Corporation (US) | 2010-01-06 | — | — | EP | disclosed |
| WO-2008075353-A1 | SULFONAMIDE DERIVATIVES WITH THERAPEUTIC INDICATIONS | PHARMOS CORPORATION (US) | 2008-06-26 | — | — | WO | disclosed |